Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
This blog series is a place for the ALS community to learn about and stay updated on ALS Canada’s advocacy efforts as well as relevant developments within government. Please note that because ALS Canada advocates federally and provincially within Ontario,...
June 13, 2022 – Today, Amylyx Pharmaceuticals, Inc announced that Health Canada has approved ALBRIOZA (AMX0035) under a Notice of Compliance with Conditions (NOC/c). This means the drug will soon...
Read the update